EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vivo Antiplasmodial Studies of Achyranthes Aspera Fractions and Molecular Docking Studies of Its Phytochemicals against Plasmodium Aspartic Proteases Targeted in Antimalarial Drug Design

Mary Matawal Mankilik, Joel Paul, Daniel Hassan Mhya, Carrol Domkat Luka, Ishaya Yohanna Longdeta

American Journal of Bioscience and Bioinformatics · 2025

DOI: 10.54536/ajbb.v4i1.4516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Bioscience and Bioinformatics, 2025. Verfasst von Mary Matawal Mankilik und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluation of fractionated extracts of Achyranthes aspera L. as an alternative antimalarial therapy is essential due to the increasing resistance of Plasmodium falciparum to artemisinin. The side effects, limited accessibility, and high cost of current drugs have intensified interest in phytochemical screening of medicinal plants as sources of bioactive compounds with antimalarial properties. The mode of action of these phytochemicals remains largely unknown, necessitating an investigation into their in vivo antimalarial activity and in silico molecular interactions with Aspartic Proteases (Plasmepsin I, II, and IV), key drug targets in malaria treatment. The in vivo antiplasmodial activity of Achyranthes aspera fractions was assessed using Rane’s curative assay in a mouse model infected intraperitoneally with 1x107 Plasmodium berghei (NK-65) parasitized RBCs per milliliter, while LC-MS techniques analyzed the phytochemical composition. In silico drug-likeness studies, including PASS, molecular docking, ADME/Tox, and Lipinski’s rule of five, were conducted, with chemical compounds docked against Plasmepsins I, II, and IV. Rane’s curative test showed significant (P

Zitieren

APA

Mankilik, M. M., Paul, J., Mhya, D. H., Luka, C. D., & Longdeta, I. Y. (2025). In Vivo Antiplasmodial Studies of Achyranthes Aspera Fractions and Molecular Docking Studies of Its Phytochemicals against Plasmodium Aspartic Proteases Targeted in Antimalarial Drug Design. American Journal of Bioscience and Bioinformatics. https://doi.org/10.54536/ajbb.v4i1.4516

Vancouver

Mankilik MM, Paul J, Mhya DH, Luka CD, Longdeta IY. In Vivo Antiplasmodial Studies of Achyranthes Aspera Fractions and Molecular Docking Studies of Its Phytochemicals against Plasmodium Aspartic Proteases Targeted in Antimalarial Drug Design. American Journal of Bioscience and Bioinformatics. 2025. doi:10.54536/ajbb.v4i1.4516

BibTeX
@article{Mankilik2025,
  author = {Mankilik, Mary Matawal and Paul, Joel and Mhya, Daniel Hassan and Luka, Carrol Domkat and Longdeta, Ishaya Yohanna},
  title = {In Vivo Antiplasmodial Studies of Achyranthes Aspera Fractions and Molecular Docking Studies of Its Phytochemicals against Plasmodium Aspartic Proteases Targeted in Antimalarial Drug Design},
  journal = {American Journal of Bioscience and Bioinformatics},
  year = {2025},
  doi = {10.54536/ajbb.v4i1.4516}
}
Kostenlos starten →